Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome.
about
Intensive care medicine research agenda on invasive fungal infection in critically ill patients.ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patientsCandida infections and their prevention.Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Mortality in patients with early- or late-onset candidaemiaAn Italian consensus for invasive candidiasis management (ITALIC).Identification and management of invasive mycoses in internal medicine: a road-map for physicians.Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings.Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections.The Changing Epidemiology of Invasive Fungal Infections.Initial antifungal strategy does not correlate with mortality in patients with candidemia.[Strategies for antifungal treatment failure in intensive care units].A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality.Molecular Confirmation of the Relationship between Candida guilliermondii Fks1p Naturally Occurring Amino Acid Substitutions and Its Intrinsic Reduced Echinocandin Susceptibility.Echinocandins in invasive candidiasis.What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead.Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries.Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata.Appropriate Duration of Intravenous Treatment of Candidemia and Timing of Step Down to Oral Therapy in Non-neutropenic Patients.
P2860
Q30235457-C7072F9C-3624-445E-9C11-4B234EE74E56Q33573788-9A1D836C-E0F1-44A3-98C0-63999ECF6BB1Q33775256-67EB05B9-EB36-4681-8B84-A15E911C1AB7Q34505582-BE2D298B-69FF-459F-A348-0570850BD685Q36675138-F6131491-88E2-4CC7-BC45-48ABD886E0E9Q38165883-6EA2118A-7E22-4E09-BC6D-8AC408C3E044Q38215670-DA2A4CA7-A913-4A9B-96FB-6B51025D09C1Q38965488-678F8EA4-77CF-42C7-A661-2E3E7274A1DAQ40168402-C714C3D5-625B-41FE-8E22-1B22F4919C49Q40454886-5F570757-A210-4FCE-B730-D476DC783481Q40883822-2501DD83-4E8B-430E-9AB6-03205CE86D40Q41010354-84553DCF-03B4-41E5-B96A-DB92B3FD4FBBQ42216247-DC953875-199E-49CF-8C3D-991A4CF59CA0Q42358865-D0A6D9C4-5750-4CBD-8DCD-DBA2265F8143Q46507142-55207A67-326A-4668-9577-AA38D62F7DBDQ47749829-DDDC13AA-6DE3-475A-BEC7-48B2FB633C56Q48163160-B4F6F646-CE36-4C71-9BA8-54E756FCA549Q52648077-F81A9C16-75DB-46F2-B810-196792827485Q54213135-B61EDB4D-81D1-40EC-94BF-B04AE4DAB357
P2860
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Anidulafungin compared with fl ...... ociated with improved outcome.
@ast
Anidulafungin compared with fl ...... ociated with improved outcome.
@en
Anidulafungin compared with fl ...... ociated with improved outcome.
@nl
type
label
Anidulafungin compared with fl ...... ociated with improved outcome.
@ast
Anidulafungin compared with fl ...... ociated with improved outcome.
@en
Anidulafungin compared with fl ...... ociated with improved outcome.
@nl
prefLabel
Anidulafungin compared with fl ...... ociated with improved outcome.
@ast
Anidulafungin compared with fl ...... ociated with improved outcome.
@en
Anidulafungin compared with fl ...... ociated with improved outcome.
@nl
P2093
P2860
P356
P1476
Anidulafungin compared with fl ...... ociated with improved outcome.
@en
P2093
Andrew F Shorr
Annette C Reboli
Arlene L Reisman
Coleman Rotstein
Daniel H Kett
Haran T Schlamm
Peter G Pappas
Pinaki Biswas
Thomas J Walsh
P2860
P2888
P356
10.1186/1471-2334-11-261
P577
2011-09-30T00:00:00Z
P5875
P6179
1040698762